Skip to content

Study · Measured the body's own peptide · 1984

1 result

Immunologic studies of the acquired immune deficiency syndrome: relationship of immunodeficiency to extent of disease.

Hersh EM, Reuben JM, Mansell PW, Rios A, Gutterman JU, Munn G, Murray JL, Spector SP, Goldstein AL, Newell GR

Annals of the New York Academy of Sciences1 Jan 1984Cited by 8 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    In 135 untreated subjects with AIDS, AIDS-related complex or no symptoms, more than half of the patients had abnormal serum thymosin alpha‑1.

    In plain wordsIn people with AIDS-related disease, more than half had abnormal levels of the body's own thymosin alpha‑1 in blood.

    Outcome
    Direction not reportedSerum thymosin alpha 1 in AIDS-related disease
    Study

    n = 135

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    More than half of all patients had abnormal percentages of lymphocytes, percentages of T3+ cells, percentage and absolute number of T4+ cells, percentage of T8+ cells, T4/T8 ratio, monocyte adherence, and serum thymosin alpha 1.
    1 context sentence
    Summary · context
    Immunologic and conventional laboratory studies were done in 135 previously untreated subjects including 28 (20.7%) symptom-free homosexuals and 74 (54.8%) with ARC and 33 (24.5%) with AIDS.

    This result measures the body's own Thymosin alpha-1. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.